|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000004653 |
|
Date of registration:
|
02/12/2010 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The clinical effects and safty of cyclosporine with rootine corticosteroid treatment in onset MCNS
|
|
Scientific title:
|
The clinical effects and safty of cyclosporine with rootine corticosteroid treatment in onset MCNS - The effects of cyclosporine in onset MCNS |
|
Date of first enrolment:
|
2005/01/01 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Complete: follow-up continuing |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003261 |
|
Study type:
|
Interventional |
|
Study design:
|
Single arm Non-randomized
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Nobuhito hirawa |
|
Address:
|
4-57 urafunecho minamiku yokohama-shi kanagawa-ken Japan
Japan |
|
Telephone:
|
045-261-5656 |
|
Email:
|
|
|
Affiliation:
|
Yokohama city university medical center division of Nephrology and Hypertension |
|
|
Name:
|
Nobuhito hirawa |
|
Address:
|
4-57 urafunecho minamiku yokohama-shi kanagawa-ken Japan
Japan |
|
Telephone:
|
045-261-5656 |
|
Email:
|
|
|
Affiliation:
|
Yokohama city university medical center division of Nephrology and Hypertension |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: minimal change nephrotic syndrome patients that have underlying disease
Age minimum:
16years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
minimal change nephrotic syndrome
|
|
Intervention(s)
|
|
cyclosporine A 2-3mg/kg/day
|
|
Primary Outcome(s)
|
|
shortening of hospitalization, reduction in adverse effects, prevention of relapse, reduction in dose of corticosteroid
|
|
Secondary Outcome(s)
|
|
reduction in days required for complete remission, blood and urine chemistry data of 6 and 12 months after discharge
|
|
Source(s) of Monetary Support
|
|
Yokohama city university graduate school of medicine
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
01/03/2012 |
|
URL:
|
|
|
|